國立高雄大學圖資館 |

Language: English

Back

Cell-based therapy for degenerative ...

Casaroli-Marano, Ricardo P.

Cell-based therapy for degenerative retinal disease

Record Type:	Electronic resources : Monograph/item
Title/Author:	Cell-based therapy for degenerative retinal diseaseedited by Marco A. Zarbin, Mandeep S. Singh, Ricardo P. Casaroli-Marano.
other author:	Zarbin, Marco A.
Published:	Cham :Springer International Publishing :2019.
Description:	xi, 280 p. :ill. (some col.), digital ;24 cm.
Contained By:	Springer eBooks
Subject:	Retinal degenerationTreatment.
Online resource:	https://doi.org/10.1007/978-3-030-05222-5
ISBN:	9783030052225$q(electronic bk.)

Cell-based therapy for degenerative retinal disease
Cell-based therapy for degenerative retinal disease[electronic resource] /edited by Marco A. Zarbin, Mandeep S. Singh, Ricardo P. Casaroli-Marano. - Cham :Springer International Publishing :2019. - xi, 280 p. :ill. (some col.), digital ;24 cm. - Stem cell biology and regenerative medicine,2196-8985. - Stem cell biology and regenerative medicine..

Advantages of the Eye as a Target Organ for Cell-Based Therapy in the Central Nervous System -- Proof of Principle: Preclinical Data on Retinal Cell Transplantation -- Clinical and Pathological Features of Selected Human Retinal Degenerative Diseases -- Degenerative Retinal Diseases: Cells sources for cell-based therapy -- Manufacturing of Clinical Grade Cellular Products Under Gmp Conditions -- Regulatory Requirements for Cell-Based Therapy for Degenerative Retinal Disease -- Biomaterials and Scaffolds for Cell Replacement Therapy -- Restoration of cone photoreceptor function in retinitis pigmentosa (RP) - retinal cell-based therapy -- Cell Delivery: Surgical Approaches -- Diagnosis and Complementary Examinations -- Cell Therapy for Degenerative Retinal Disease: special focus on cell fusion-mediated regeneration -- Clinical Trials of Retinal Cell Therapy -- Future Directions -- Index.

This book discusses why specific diseases are being targeted for cell-based retinal therapy, what evidence exists that justifies optimism for this approach, and what challenges must be managed in order to bring this technology from the laboratory into routine clinical practice. There are a number of unanswered questions (e.g., surgical approach to cell delivery, management of immune response, optimum cell type to transplant) that very likely are not going to be answered until human trials are undertaken, but there is a certain amount of "de-risking" that can be done with preclinical experimentation. This book is essential reading for scientists, clinicians, and advanced students in stem cell research, cell biology, and ophthalmology.

ISBN: 9783030052225$q(electronic bk.)

Standard No.: 10.1007/978-3-030-05222-5doiSubjects--Topical Terms:

725309
Retinal degeneration
--Treatment.

LC Class. No.: RE661.D3 / C455 2019

Dewey Class. No.: 617.735

Cell-based therapy for degenerative retinal disease
LDR:02752nmm a2200337 a 4500 001 553548
003 DE-He213
005 20190827114641.0
006 m d
007 cr nn 008maaau
008 191112s2019 gw s 0 eng d
020 $a 9783030052225$q(electronic bk.)
020 $a 9783030052218$q(paper)
024 7 $a 10.1007/978-3-030-05222-5 $2 doi
035 $a 978-3-030-05222-5
040 $a GP $c GP
041 0 $a eng
050 4 $a RE661.D3 $b C455 2019
072 7 $a PSAK $2 bicssc
072 7 $a SCI017000 $2 bisacsh
072 7 $a PSAK $2 thema
082 0 4 $a 617.735 $2 23
090 $a RE661.D3 $b C393 2019
245 0 0 $a Cell-based therapy for degenerative retinal disease $h [electronic resource] / $c edited by Marco A. Zarbin, Mandeep S. Singh, Ricardo P. Casaroli-Marano.
260 $a Cham : $b Springer International Publishing : $b Imprint: Humana Press, $c 2019.
300 $a xi, 280 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a Stem cell biology and regenerative medicine, $x 2196-8985
505 0 $a Advantages of the Eye as a Target Organ for Cell-Based Therapy in the Central Nervous System -- Proof of Principle: Preclinical Data on Retinal Cell Transplantation -- Clinical and Pathological Features of Selected Human Retinal Degenerative Diseases -- Degenerative Retinal Diseases: Cells sources for cell-based therapy -- Manufacturing of Clinical Grade Cellular Products Under Gmp Conditions -- Regulatory Requirements for Cell-Based Therapy for Degenerative Retinal Disease -- Biomaterials and Scaffolds for Cell Replacement Therapy -- Restoration of cone photoreceptor function in retinitis pigmentosa (RP) - retinal cell-based therapy -- Cell Delivery: Surgical Approaches -- Diagnosis and Complementary Examinations -- Cell Therapy for Degenerative Retinal Disease: special focus on cell fusion-mediated regeneration -- Clinical Trials of Retinal Cell Therapy -- Future Directions -- Index.
520 $a This book discusses why specific diseases are being targeted for cell-based retinal therapy, what evidence exists that justifies optimism for this approach, and what challenges must be managed in order to bring this technology from the laboratory into routine clinical practice. There are a number of unanswered questions (e.g., surgical approach to cell delivery, management of immune response, optimum cell type to transplant) that very likely are not going to be answered until human trials are undertaken, but there is a certain amount of "de-risking" that can be done with preclinical experimentation. This book is essential reading for scientists, clinicians, and advanced students in stem cell research, cell biology, and ophthalmology.
650 0 $a Retinal degeneration $x Treatment. $3 725309
650 0 $a Stem cells $x Therapeutic use. $3 455512
650 1 4 $a Stem Cells. $3 203924
650 2 4 $a Regenerative Medicine/Tissue Engineering. $3 675875
650 2 4 $a Ophthalmology. $3 274149
700 1 $a Zarbin, Marco A. $3 725308
700 1 $a Singh, Mandeep S. $3 834924
700 1 $a Casaroli-Marano, Ricardo P. $3 834925
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Stem cell biology and regenerative medicine. $3 558395
856 4 0 $u https://doi.org/10.1007/978-3-030-05222-5
950 $a Biomedical and Life Sciences (Springer-11642)